The Weekly | A Secret Opioid Memo That Could Have Slowed an Epidemic


Producer/Director John Pappas

A confidential government document containing evidence so critical it had the potential to change the course of an American tragedy was kept in the dark for more than a decade. The document, known as a “prosecution memo,” details how government lawyers believed that Purdue Pharma, the maker of the powerful opioid, OxyContin, knew early on that the drug was fueling a rise in abuse and addiction. They also gathered evidence indicating that the company’s executives had misled the public and Congress.

“The Weekly” shines a light on that 2006 Justice Department memo and its consequences for today’s wave of lawsuits against opioid makers and members of the Sackler family, which owns Purdue Pharma. We go with Barry Meier, the New York Times reporter who for two decades has chronicled how opioid abuse has ravaged America, as he travels back to where the crisis began.

[Join the conversation about @theweekly on Twitter and Instagram. #TheWeeklyNYT]

Prosecutors cited evidence in their 2006 memo that Sackler family members who own Purdue were sent reports about problems with the company’s drugs. But that evidence never came to light because the recommended felony charges against Purdue executives never went forward.

Instead, three executives, under a deal with the government, pleaded guilty to a misdemeanor that did not accuse them of wrongdoing. They had insisted they did nothing wrong, and the company denied there was a cover-up, saying that executives did not learn of problems with OxyContin until 2000. Prosecutors, in their memo, did not accuse the Sacklers of any wrongdoing and Dr. Richard Sackler has since testified he was unaware of any illegal activities at Purdue.

What follows are annotated excerpts from that memo used in reporting for this episode of “The Weekly.”

Advanced Warning

Prosecutors wrote that Purdue covered up OxyContin’s early abuse. Its executives said they only learned about the problem in early 2000.

Marketing

Dr. Sackler apparently pushed in 1997, prosecutors wrote, for videos promoting OxyContin in response to “concerns raised about the abuse potential.”

Potential for Abuse

Prosecutors believed that Purdue had concealed widespread abuse of OxyContin’s predecessor drug, MS Contin. It too was a long-acting opioid, a formulation that Purdue claimed made OxyContin less prone to abuse.

Internet Chatter

Dr. Sackler was sent an email in 1999, prosecutors found, that discussed how people in internet chat rooms were talking about snorting OxyContin.

Rick Mountcastle, who led the Justice Department investigation into Purdue Pharma, moved from the Abingdon, Va., office to Roanoke after that case in 2007. He continued as an assistant U.S. attorney, and served for 15 months as U.S. Attorney for the Western District of Virginia until President Trump appointed a new U.S. attorney in 2018. Mountcastle retired from the Justice Department last December.

Paul Pelletier, a former deputy chief of the fraud section at the criminal division of the Justice Department, left the government in 2011 and is a lawyer in private practice in Northern Virginia. He ran for Congress in 2018 as a Democrat in Virginia’s 10th Congressional District, but lost in the primary.

Maura Healey, the attorney general of Massachusetts, leads one of the many lawsuits filed against Purdue, its executives and members of the Sackler family. Earlier this year, she released emails from 2001 in which Dr. Richard Sackler blamed drug abusers for the company’s problems. “We have to hammer on the abusers in every possible way,” Sackler wrote. Two weeks ago, Purdue’s lawyers asked a judge in Massachusetts to dismiss the case.

The Sackler family purchased the company that would become Purdue Pharma in the 1950s, and some of the family’s heirs, who made a fortune from sales of OxyContin, are now defendants in lawsuits brought against the company for its role in fueling the opioid epidemic. The Sacklers have donated generously to museums around the world, but some of those institutions — including the Metropolitan Museum of Art and the Guggenheim in New York, the Tate museums in London, and the Louvre in Paris — have sought to sever ties with the family.



Sahred From Source link Health

Leave a Reply

Your email address will not be published. Required fields are marked *